Svenstrup, Niels,Simonsen, Klaus Baek,Rasmussen, Lars Kyhn,Juhl, Karsten,Langgard, Morten,Wen, Kate,Wang, Yazhou
申请号：
AU2013213603
公开号：
AU2013213603B2
申请日:
2013.01.25
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
This invention is directed to compounds, which are PDE9 enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention further provides a compound of formula(l) for use in a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I).
